Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 229

1.

An economic analysis of cisplatin alone versus cisplatin doublets in the treatment of women with advanced or recurrent cervical cancer.

McKim A, Walter AC, Sheely KM, Manahan KJ, Geisler JP.

Eur J Gynaecol Oncol. 2016;37(3):353-6.

PMID:
27352563
2.

Treatment with aromatase inhibitors stimulates the expression of Epidermal growth factor receptor-1 and Neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers.

Flågeng MH, Larionov A, Geisler J, Knappskog S, Prestvik WS, Bjørkøy G, Lilleng PK, Dixon JM, Miller WR, Lønning PE, Mellgren G.

J Steroid Biochem Mol Biol. 2016 Jun 22. pii: S0960-0760(16)30183-2. doi: 10.1016/j.jsbmb.2016.06.011. [Epub ahead of print]

PMID:
27343990
3.

Vascular endothelial growth factor (VEGF) and cyclooxygenase 2 (COX 2) immunostaining in ovarian cancer.

Whynott RM, Manahan P, Geisler JP.

Eur J Gynaecol Oncol. 2016;37(2):164-6.

PMID:
27172738
4.

Recurrent Pseudomembranous Colitis in an Ovarian Cancer Patient Undergoing Carboplatin Chemotherapy.

Allen VA, Manahan KJ, Geisler JP.

Case Rep Obstet Gynecol. 2016;2016:7540302. doi: 10.1155/2016/7540302. Epub 2016 Mar 8.

5.

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.

Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T.

Eur Heart J. 2016 Jun 1;37(21):1671-80. doi: 10.1093/eurheartj/ehw022. Epub 2016 Feb 21. Review.

6.

Breast Cancer is Common in Women With Ovarian Malignant Mixed Mullerian Tumors.

Whynott RM, Manahan KJ, Geisler JP.

Am J Clin Oncol. 2016 Jan 11. [Epub ahead of print]

PMID:
26757435
7.

Electrosurgical Settings and Vaginal Cuff Complications.

Lawlor ML, Rao R, Manahan KJ, Geisler JP.

JSLS. 2015 Sep-Dec;19(4). pii: e2015.00088. doi: 10.4293/JSLS.2015.00088.

8.

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes.

Lauss M, Ringnér M, Karlsson A, Harbst K, Busch C, Geisler J, Lønning PE, Staaf J, Jönsson G.

BMC Med Genomics. 2015 Nov 6;8:73. doi: 10.1186/s12920-015-0147-4.

9.

Modular Assembly of Allosteric MEK Inhibitor Structural Elements Unravels Potency and Feedback-Modulation Handles.

Hartung IV, Pühler F, Neuhaus R, Scholz A, Siemeister G, Geisler J, Hillig RC, von Ahsen O, Hitchcock M.

ChemMedChem. 2015 Dec;10(12):2004-13. doi: 10.1002/cmdc.201500442. Epub 2015 Nov 6.

PMID:
26541480
10.

The epidermal growth factor receptor (EGFR / HER-1) gatekeeper mutation T790M is present in European patients with early breast cancer.

Bemanian V, Sauer T, Touma J, Lindstedt BA, Chen Y, Ødegård HP, Vetvik KM, Bukholm IR, Geisler J.

PLoS One. 2015 Aug 12;10(8):e0134398. doi: 10.1371/journal.pone.0134398. eCollection 2015.

11.

Cyclin E is overexpressed by clear cell carcinomas of the endometrium and is a prognostic indicator of survival.

Zapiecki K, Manahan KJ, Miller GA, Geisler JP.

Eur J Gynaecol Oncol. 2015;36(2):114-6.

PMID:
26050345
12.

Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.

Lauss M, Haq R, Cirenajwis H, Phung B, Harbst K, Staaf J, Rosengren F, Holm K, Aine M, Jirström K, Borg Å, Busch C, Geisler J, Lønning PE, Ringnér M, Howlin J, Fisher DE, Jönsson G.

J Invest Dermatol. 2015 Jul;135(7):1820-8. doi: 10.1038/jid.2015.61. Epub 2015 Feb 23.

13.

[Advanced radioiodine-refractory differentiated thyroid cancer].

Spitzweg C, Auernhammer CJ, Geisler J, Böck S, Heinemann V, Bartenstein P, Göke B.

Dtsch Med Wochenschr. 2015 Feb;140(3):168-71. doi: 10.1055/s-0041-100196. Epub 2015 Feb 6. Review. German. No abstract available.

PMID:
25658401
14.

Tumor phosphatidylinositol 3-kinase signaling in therapy resistance and metastatic dissemination of rectal cancer: opportunities for signaling-adapted therapies.

Ree AH, Flatmark K, Saelen MG, Folkvord S, Dueland S, Geisler J, Redalen KR.

Crit Rev Oncol Hematol. 2015 Jul;95(1):114-24. doi: 10.1016/j.critrevonc.2015.01.003. Epub 2015 Jan 12.

PMID:
25624177
15.

Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens.

Løes IM, Immervoll H, Angelsen JH, Horn A, Geisler J, Busch C, Lønning PE, Knappskog S.

Tumour Biol. 2015 Feb;36(2):1003-13. doi: 10.1007/s13277-014-2711-5. Epub 2014 Oct 16.

16.

Assessment of False-negative Ascites Cytology in Epithelial Ovarian Carcinoma: A Study of 313 Patients.

Allen VA, Takashima Y, Nayak S, Manahan KJ, Geisler JP.

Am J Clin Oncol. 2014 Sep 5. [Epub ahead of print]

PMID:
25198110
17.
18.

A new fossil species supports an early origin for toothed whale echolocation.

Geisler JH, Colbert MW, Carew JL.

Nature. 2014 Apr 17;508(7496):383-6. doi: 10.1038/nature13086. Epub 2014 Mar 12.

PMID:
24670659
19.

D-chiro-inositol glycan stimulates insulin secretion in pancreatic β cells.

Lazarenko R, Geisler J, Bayliss D, Larner J, Li C.

Mol Cell Endocrinol. 2014 Apr 25;387(1-2):1-7. doi: 10.1016/j.mce.2014.02.004. Epub 2014 Feb 14.

20.

[Norwegian Melanoma Group (NMG) replies].

Geisler J.

Tidsskr Nor Laegeforen. 2014 Jan 14;134(1):9. doi: 10.4045/tidsskr.13.1569. Norwegian. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk